Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia.
D000971:Antineoplastic Combined Chemotherapy Protocols; D001772:Blood Cell Count; D001792:Blood Platelets / Q000473:pathology; D002453:Cell Cycle; D003561:Cytarabine / Q000008:administration & dosage*; D003630:Daunorubicin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy*; D008297:Male; D009504:Neutrophils / Q000473:pathology; D011446:Prospective Studies; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage*
D003561:Cytarabine; D014750:Vincristine; D003630:Daunorubicin